The delivery of personalized healthcare is causing a power shift with new entrants disrupting incumbents. Innovation, productivity and access to patients challenge every link in the life sciences value chain, from RD and product supply to product launch and patient-centric operating models.

EY Life Sciences brings together a worldwide network of 23,000 sector professionals to anticipate trends, identify implications and help clients create competitive advantage in a health outcomes-driven ecosystem.